,,,CTRL2/CTRL1,CTRL3/CTRL1,CTRL3/CTRL2,,,,,,,
Reactome pathways,number,overUnder,fdr,fdr,fdr,,,,,,,
Immune System (R-MMU-168256),63,+,9.91E-01,8.63E-01,8.25E-01,,,,,,,
Signal Transduction (R-MMU-162582),56,+,5.86E-01,8.95E-01,9.38E-01,,,,,,,
Metabolism (R-MMU-1430728),48,-,5.93E-01,7.97E-01,8.56E-01,,,,,,,
Innate Immune System (R-MMU-168249),48,+,1.00E+00,8.77E-01,8.87E-01,,,,,,,
Developmental Biology (R-MMU-1266738),47,+,8.36E-01,8.61E-01,9.67E-01,,,,,,,
Metabolism of proteins (R-MMU-392499),43,-,5.58E-01,2.26E+00,9.82E-01,,,,,,,
Neutrophil degranulation (R-MMU-6798695),37,+,9.22E-01,9.84E-01,8.29E-01,,,,,,,
Post-translational protein modification (R-MMU-597592),35,-,5.50E-01,8.27E-01,9.56E-01,,,Analysis Type:,PANTHER Enrichment Test (release 20181003),,,
Cellular responses to stress (R-MMU-2262752),32,-,5.94E-01,8.63E-01,1.29E+00,,,Annotation Version and Release Date:,Reactome version 65 Released 2018-06-12,,,
Cellular responses to external stimuli (R-MMU-8953897),32,-,5.93E-01,8.59E-01,9.59E-01,,,Analyzed List:,test.txt (Mus musculus),,,"There are duplicate IDs in the file.   For duplicates, the first id/value pair in the file will be used."
Keratinization (R-MMU-6805567),32,-,8.59E-01,8.24E-01,9.57E-01,,,Correction:,FDR,,,
Formation of the cornified envelope (R-MMU-6809371),31,-,9.10E-01,9.29E-01,1.34E+00,,,,,,,
Hemostasis (R-MMU-109582),29,-,9.58E-01,8.91E-01,1.21E+00,,,,,,,
Metabolism of RNA (R-MMU-8953854),25,-,2.22E+00,2.11E+00,8.15E-01,,,,,,,
Muscle contraction (R-MMU-397014),24,-,6.91E-01,8.89E-01,8.20E-01,,,,,,,
Vesicle-mediated transport (R-MMU-5653656),23,-,9.41E-01,8.87E-01,9.39E-01,,,,,,,
"Platelet activation, signaling and aggregation (R-MMU-76002)",21,-,8.14E-01,8.44E-01,7.79E-01,,,,,,,
Adaptive Immune System (R-MMU-1280218),21,+,9.97E-01,9.24E-01,9.74E-01,,,,,,,
Signaling by Rho GTPases (R-MMU-194315),19,+,2.31E+00,4.38E+00,8.02E-01,,,,,,,
Gene expression (Transcription) (R-MMU-74160),19,-,5.64E-01,8.77E-01,8.35E-01,,,,,,,
Cell Cycle (R-MMU-1640170),19,+,7.35E-01,9.01E-01,8.33E-01,,,,,,,
Response to elevated platelet cytosolic Ca2+ (R-MMU-76005),19,-,9.26E-01,8.99E-01,8.28E-01,,,,,,,
Platelet degranulation  (R-MMU-114608),19,-,9.25E-01,9.82E-01,8.96E-01,,,,,,,
RHO GTPase Effectors (R-MMU-195258),18,+,2.29E+00,4.11E+00,2.00E+00,,,,,,,
Extracellular matrix organization (R-MMU-1474244),18,+,6.26E-01,8.43E-01,1.24E+00,,,,,,,
Metabolism of carbohydrates (R-MMU-71387),18,-,5.89E-01,8.63E-01,8.19E-01,,,,,,,
"Cell Cycle, Mitotic (R-MMU-69278)",18,+,7.44E-01,9.93E-01,9.58E-01,,,,,,,
Transport of small molecules (R-MMU-382551),17,-,3.76E+00,8.32E+00,8.86E-01,,,,,,,
Striated Muscle Contraction (R-MMU-390522),17,-,8.82E-01,8.87E-01,9.43E-01,,,,,,,
RNA Polymerase II Transcription (R-MMU-73857),16,-,6.46E-01,8.84E-01,8.82E-01,,,,,,,
Membrane Trafficking (R-MMU-199991),16,+,7.88E-01,8.64E-01,9.42E-01,,,,,,,
Axon guidance (R-MMU-422475),15,+,5.79E-01,8.49E-01,1.16E+00,,,,,,,
Generic Transcription Pathway (R-MMU-212436),15,-,6.93E-01,8.93E-01,9.42E-01,,,,,,,
M Phase (R-MMU-68886),15,+,7.48E-01,9.73E-01,9.94E-01,,,,,,,
Programmed Cell Death (R-MMU-5357801),13,+,5.83E-01,8.42E-01,9.37E-01,,,,,,,
Post-translational protein phosphorylation (R-MMU-8957275),13,-,8.05E-01,8.89E-01,9.58E-01,,,,,,,
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) (R-MMU-381426),13,-,8.04E-01,8.86E-01,9.56E-01,,,,,,,
Cellular response to heat stress (R-MMU-3371556),13,-,8.74E-01,9.93E-01,9.57E-01,,,,,,,
Apoptosis (R-MMU-109581),12,+,5.83E-01,7.48E-01,7.86E-01,,,,,,,
MAPK family signaling cascades (R-MMU-5683057),12,+,6.15E-01,8.45E-01,9.51E-01,,,,,,,
Processing of Capped Intron-Containing Pre-mRNA (R-MMU-72203),12,-,6.23E-01,8.84E-01,9.57E-01,,,,,,,
Signaling by Receptor Tyrosine Kinases (R-MMU-9006934),11,-,5.98E-01,8.96E-01,9.58E-01,,,,,,,
mRNA Splicing (R-MMU-72172),11,-,5.54E-01,8.75E-01,9.95E-01,,,,,,,
mRNA Splicing - Major Pathway (R-MMU-72163),11,-,5.52E-01,8.72E-01,9.93E-01,,,,,,,
RAF/MAP kinase cascade (R-MMU-5673001),11,+,5.68E-01,9.31E-01,9.96E-01,,,,,,,
MAPK1/MAPK3 signaling (R-MMU-5684996),11,+,5.67E-01,9.28E-01,9.95E-01,,,,,,,
Collagen formation (R-MMU-1474290),10,+,5.30E-01,8.80E-01,1.79E+00,,,,,,,
Apoptotic execution phase (R-MMU-75153),10,+,5.85E-01,8.86E-01,1.25E+00,,,,,,,
Metabolism of lipids (R-MMU-556833),10,-,6.84E-01,8.83E-01,1.17E+00,,,,,,,
Degradation of the extracellular matrix (R-MMU-1474228),10,+,6.91E-01,8.83E-01,1.17E+00,,,,,,,
Transcriptional Regulation by TP53 (R-MMU-3700989),10,-,7.85E-01,8.11E-01,7.26E-01,,,,,,,
Asparagine N-linked glycosylation (R-MMU-446203),10,-,9.23E-01,8.10E-01,7.90E-01,,,,,,,
Organelle biogenesis and maintenance (R-MMU-1852241),10,+,9.37E-01,8.66E-01,7.94E-01,,,,,,,
HSP90 chaperone cycle for steroid hormone receptors (SHR) (R-MMU-3371497),10,-,9.56E-01,9.19E-01,7.96E-01,,,,,,,
Mitotic G2-G2/M phases (R-MMU-453274),10,-,9.49E-01,9.57E-01,9.34E-01,,,,,,,
G2/M Transition (R-MMU-69275),10,-,9.48E-01,9.86E-01,9.66E-01,,,,,,,
Glucose metabolism (R-MMU-70326),9,-,7.21E-01,8.13E-01,2.20E+00,,,,,,,
Mitotic Prometaphase (R-MMU-68877),9,+,5.45E-01,8.39E-01,8.27E-01,,,,,,,
Detoxification of Reactive Oxygen Species (R-MMU-3299685),9,-,5.84E-01,9.09E-01,8.32E-01,,,,,,,
Apoptotic cleavage of cellular proteins (R-MMU-111465),9,+,6.08E-01,9.27E-01,7.89E-01,,,,,,,
Cell Cycle Checkpoints (R-MMU-69620),9,+,6.70E-01,9.27E-01,7.99E-01,,,,,,,
The citric acid (TCA) cycle and respiratory electron transport (R-MMU-1428517),9,+,9.52E-01,9.03E-01,8.64E-01,,,,,,,
Glycolysis (R-MMU-70171),8,-,1.88E+00,7.94E-01,1.67E+00,,,,,,,
Class I MHC mediated antigen processing & presentation (R-MMU-983169),8,-,5.95E-01,8.23E-01,1.32E+00,,,,,,,
Assembly of collagen fibrils and other multimeric structures (R-MMU-2022090),8,+,5.96E-01,8.26E-01,1.24E+00,,,,,,,
Regulation of mRNA stability by proteins that bind AU-rich elements (R-MMU-450531),8,-,5.82E-01,9.34E-01,1.16E+00,,,,,,,
MHC class II antigen presentation (R-MMU-2132295),8,+,5.69E-01,7.99E-01,9.72E-01,,,,,,,
Signaling by WNT (R-MMU-195721),8,-,5.71E-01,8.70E-01,7.87E-01,,,,,,,
Regulation of HSF1-mediated heat shock response (R-MMU-3371453),8,-,6.93E-01,8.87E-01,8.81E-01,,,,,,,
L1CAM interactions (R-MMU-373760),8,+,8.11E-01,8.88E-01,9.31E-01,,,,,,,
Signaling by Nuclear Receptors (R-MMU-9006931),8,+,8.70E-01,9.25E-01,9.34E-01,,,,,,,
Toll-Like Receptors Cascades (R-MMU-168898),8,+,9.15E-01,9.24E-01,9.41E-01,,,,,,,
Regulation of PLK1 Activity at G2/M Transition (R-MMU-2565942),8,+,9.67E-01,9.77E-01,9.58E-01,,,,,,,
Smooth Muscle Contraction (R-MMU-445355),8,+,1.01E+00,9.87E-01,9.95E-01,,,,,,,
RHO GTPases Activate Formins (R-MMU-5663220),7,+,2.60E+00,2.79E+00,1.64E+00,,,,,,,
Gluconeogenesis (R-MMU-70263),7,-,6.14E-01,6.98E-01,1.32E+00,,,,,,,
Cell-Cell communication (R-MMU-1500931),7,+,5.33E-01,8.21E-01,1.30E+00,,,,,,,
Cytokine Signaling in Immune system (R-MMU-1280215),7,-,5.92E-01,8.25E-01,7.55E-01,,,,,,,
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) (R-MMU-975957),7,-,5.86E-01,8.99E-01,7.52E-01,,,,,,,
Nonsense-Mediated Decay (NMD) (R-MMU-927802),7,-,5.83E-01,8.96E-01,7.49E-01,,,,,,,
Binding and Uptake of Ligands by Scavenger Receptors (R-MMU-2173782),7,-,6.67E-01,8.93E-01,8.26E-01,,,,,,,
Recruitment of NuMA to mitotic centrosomes (R-MMU-380320),7,+,5.85E-01,9.10E-01,8.31E-01,,,,,,,
TP53 Regulates Metabolic Genes (R-MMU-5628897),7,-,6.31E-01,9.79E-01,8.51E-01,,,,,,,
Mitotic Anaphase (R-MMU-68882),7,+,7.04E-01,9.77E-01,9.41E-01,,,,,,,
Mitotic Metaphase and Anaphase (R-MMU-2555396),7,+,7.02E-01,9.75E-01,9.85E-01,,,,,,,
Separation of Sister Chromatids (R-MMU-2467813),7,+,7.01E-01,9.80E-01,9.78E-01,,,,,,,
MAP2K and MAPK activation (R-MMU-5674135),6,+,4.73E-01,2.33E+00,1.32E+01,,,,,,,
Signaling by Interleukins (R-MMU-449147),6,-,5.23E-01,7.99E-01,6.61E+00,,,,,,,
Signaling by Hedgehog (R-MMU-5358351),6,-,5.32E-01,8.00E-01,4.40E+00,,,,,,,
Collagen biosynthesis and modifying enzymes (R-MMU-1650814),6,+,5.73E-01,7.97E-01,3.30E+00,,,,,,,
Cell junction organization (R-MMU-446728),6,+,6.23E-01,8.32E-01,2.64E+00,,,,,,,
HSF1-dependent transactivation (R-MMU-3371571),6,-,5.83E-01,8.49E-01,2.20E+00,,,,,,,
Attenuation phase (R-MMU-3371568),6,-,5.81E-01,8.81E-01,1.89E+00,,,,,,,
Integrin cell surface interactions (R-MMU-216083),6,+,5.83E-01,8.83E-01,1.91E+00,,,,,,,
Intra-Golgi and retrograde Golgi-to-ER traffic (R-MMU-6811442),6,+,5.87E-01,8.80E-01,1.83E+00,,,,,,,
Golgi-to-ER retrograde transport (R-MMU-8856688),6,+,5.86E-01,9.10E-01,7.31E-01,,,,,,,
Anchoring of the basal body to the plasma membrane (R-MMU-5620912),6,+,6.00E-01,9.23E-01,8.33E-01,,,,,,,
Centrosome maturation (R-MMU-380287),6,+,5.99E-01,9.31E-01,8.34E-01,,,,,,,
Loss of proteins required for interphase microtubule organization√°from the centrosome (R-MMU-380284),6,+,5.97E-01,9.38E-01,8.28E-01,,,,,,,
Recruitment of mitotic centrosome proteins and complexes (R-MMU-380270),6,+,5.96E-01,9.30E-01,8.26E-01,,,,,,,
Loss of Nlp from mitotic centrosomes (R-MMU-380259),6,+,5.94E-01,9.28E-01,7.91E-01,,,,,,,
Cilium Assembly (R-MMU-5617833),6,+,5.93E-01,9.10E-01,8.09E-01,,,,,,,
AURKA Activation by TPX2 (R-MMU-8854518),6,+,5.91E-01,9.80E-01,8.93E-01,,,,,,,
HSF1 activation (R-MMU-3371511),6,+,5.96E-01,9.79E-01,8.98E-01,,,,,,,
"Plasma lipoprotein assembly, remodeling, and clearance (R-MMU-174824)",6,-,6.36E-01,1.00E+00,9.43E-01,,,,,,,
Cellular Senescence (R-MMU-2559583),6,-,6.42E-01,1.00E+00,9.45E-01,,,,,,,
RHO GTPases activate PAKs (R-MMU-5627123),6,+,7.45E-01,9.98E-01,9.43E-01,,,,,,,
Regulation of actin dynamics for phagocytic cup formation (R-MMU-2029482),6,-,7.53E-01,9.97E-01,9.49E-01,,,,,,,
Fcgamma receptor (FCGR) dependent phagocytosis (R-MMU-2029480),6,-,7.51E-01,9.95E-01,9.76E-01,,,,,,,
Metabolism of amino acids and derivatives (R-MMU-71291),6,-,9.24E-01,9.94E-01,9.78E-01,,,,,,,
Recycling pathway of L1 (R-MMU-437239),6,-,9.61E-01,9.92E-01,9.96E-01,,,,,,,
Resolution of Sister Chromatid Cohesion (R-MMU-2500257),5,+,6.37E-01,1.55E+00,1.81E+00,,,,,,,
DNA Repair (R-MMU-73894),5,-,4.63E-01,1.51E+00,1.88E+00,,,,,,,
Antigen processing: Ubiquitination & Proteasome degradation (R-MMU-983168),5,-,4.72E-01,7.53E-01,1.87E+00,,,,,,,
Translation (R-MMU-72766),5,-,4.71E-01,8.02E-01,1.66E+00,,,,,,,
N-glycan trimming in the ER and Calnexin/Calreticulin cycle (R-MMU-532668),5,-,5.72E-01,8.00E-01,1.38E+00,,,,,,,
The role of GTSE1 in G2/M progression after G2 checkpoint (R-MMU-8852276),5,-,5.80E-01,8.35E-01,1.21E+00,,,,,,,
AUF1 (hnRNP D0) binds and destabilizes mRNA (R-MMU-450408),5,-,5.92E-01,8.38E-01,1.20E+00,,,,,,,
Scavenging of heme from plasma (R-MMU-2168880),5,-,5.67E-01,8.27E-01,1.19E+00,,,,,,,
Clathrin-mediated endocytosis (R-MMU-8856828),5,-,5.67E-01,8.28E-01,1.18E+00,,,,,,,
Deubiquitination (R-MMU-5688426),5,-,5.69E-01,8.83E-01,7.78E-01,,,,,,,
G2/M Checkpoints (R-MMU-69481),5,-,6.35E-01,8.91E-01,8.09E-01,,,,,,,
Oxidative Stress Induced Senescence (R-MMU-2559580),5,-,6.94E-01,9.01E-01,8.37E-01,,,,,,,
ER to Golgi Anterograde Transport (R-MMU-199977),5,+,6.91E-01,8.62E-01,8.00E-01,,,,,,,
Transport to the Golgi and subsequent modification (R-MMU-948021),5,+,6.89E-01,8.60E-01,8.16E-01,,,,,,,
COPI-mediated anterograde transport (R-MMU-6807878),5,+,6.86E-01,8.59E-01,8.14E-01,,,,,,,
ECM proteoglycans (R-MMU-3000178),5,+,6.86E-01,8.65E-01,8.12E-01,,,,,,,
Transcriptional regulation by RUNX1 (R-MMU-8878171),5,-,7.10E-01,9.08E-01,9.34E-01,,,,,,,
Collagen degradation (R-MMU-1442490),5,+,7.17E-01,9.07E-01,9.32E-01,,,,,,,
GPCR downstream signalling (R-MMU-388396),5,-,7.56E-01,9.24E-01,9.30E-01,,,,,,,
G alpha (i) signalling events (R-MMU-418594),5,-,7.54E-01,9.86E-01,9.42E-01,,,,,,,
Signaling by GPCR (R-MMU-372790),5,-,7.53E-01,9.85E-01,9.59E-01,,,,,,,
Estrogen-dependent gene expression (R-MMU-9018519),5,+,9.24E-01,9.83E-01,9.63E-01,,,,,,,
ESR-mediated signaling (R-MMU-8939211),5,+,9.23E-01,9.82E-01,9.57E-01,,,,,,,
"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. (R-MMU-163200)",5,-,9.30E-01,9.76E-01,9.92E-01,,,,,,,
Mitotic Prophase (R-MMU-68875),5,+,9.98E-01,9.95E-01,9.96E-01,,,,,,,
Mitotic Spindle Checkpoint (R-MMU-69618),4,+,3.41E+00,4.98E+00,1.59E+00,,,,,,,
Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal (R-MMU-141444),4,+,2.27E+00,4.17E+00,1.96E+00,,,,,,,
Amplification of signal from the kinetochores (R-MMU-141424),4,+,1.70E+00,3.71E+00,1.76E+00,,,,,,,
Interleukin-1 family signaling (R-MMU-446652),4,-,2.06E+00,3.34E+00,1.71E+00,,,,,,,
Interleukin-1 signaling (R-MMU-9020702),4,-,1.87E+00,3.04E+00,1.65E+00,,,,,,,
ABC-family proteins mediated transport (R-MMU-382556),4,-,1.83E+00,2.08E+00,1.71E+00,,,,,,,
Hedgehog 'off' state (R-MMU-5610787),4,-,1.83E+00,1.72E+00,1.68E+00,,,,,,,
Iron uptake and transport (R-MMU-917937),4,-,7.15E-01,1.68E+00,1.37E+00,,,,,,,
Mitotic G1-G1/S phases (R-MMU-453279),4,-,6.24E-01,1.58E+00,1.35E+00,,,,,,,
Signaling by FGFR (R-MMU-190236),4,-,6.06E-01,7.15E-01,1.34E+00,,,,,,,
Signaling by FGFR2 (R-MMU-5654738),4,-,6.00E-01,7.38E-01,1.32E+00,,,,,,,
Neddylation (R-MMU-8951664),4,-,5.86E-01,8.01E-01,1.33E+00,,,,,,,
Beta-catenin independent WNT signaling (R-MMU-3858494),4,-,5.79E-01,8.25E-01,1.18E+00,,,,,,,
PCP/CE pathway (R-MMU-4086400),4,-,5.75E-01,8.20E-01,1.17E+00,,,,,,,
Hedgehog ligand biogenesis (R-MMU-5358346),4,-,5.79E-01,8.39E-01,1.16E+00,,,,,,,
TCF dependent signaling in response to WNT (R-MMU-201681),4,-,5.75E-01,8.35E-01,9.85E-01,,,,,,,
"Formation of the ternary complex, and subsequently, the 43S complex (R-MMU-72695)",4,-,6.00E-01,8.30E-01,9.80E-01,,,,,,,
Eukaryotic Translation Initiation (R-MMU-72613),4,-,5.97E-01,8.51E-01,7.79E-01,,,,,,,
Cap-dependent Translation Initiation (R-MMU-72737),4,-,5.94E-01,8.27E-01,7.76E-01,,,,,,,
Ribosomal scanning and start codon recognition (R-MMU-72702),4,-,5.91E-01,8.23E-01,8.26E-01,,,,,,,
Calnexin/calreticulin cycle (R-MMU-901042),4,-,6.12E-01,8.33E-01,8.30E-01,,,,,,,
CLEC7A (Dectin-1) signaling (R-MMU-5607764),4,-,6.15E-01,8.43E-01,8.28E-01,,,,,,,
C-type lectin receptors (CLRs) (R-MMU-5621481),4,-,6.13E-01,9.10E-01,8.37E-01,,,,,,,
Signaling by the B Cell Receptor (BCR) (R-MMU-983705),4,-,6.50E-01,9.09E-01,8.39E-01,,,,,,,
UCH proteinases (R-MMU-5689603),4,-,5.50E-01,9.06E-01,8.44E-01,,,,,,,
Cell-extracellular matrix interactions (R-MMU-446353),4,+,5.62E-01,9.03E-01,8.00E-01,,,,,,,
RHO GTPases activate IQGAPs (R-MMU-5626467),4,+,5.63E-01,9.00E-01,8.84E-01,,,,,,,
Glycosaminoglycan metabolism (R-MMU-1630316),4,+,5.64E-01,9.04E-01,8.80E-01,,,,,,,
Collagen chain trimerization (R-MMU-8948216),4,+,5.83E-01,9.01E-01,8.78E-01,,,,,,,
COPI-independent Golgi-to-ER retrograde traffic (R-MMU-6811436),4,+,6.34E-01,9.33E-01,8.77E-01,,,,,,,
RHO GTPases activate PKNs (R-MMU-5625740),4,+,6.84E-01,8.02E-01,8.95E-01,,,,,,,
Formation of ATP by chemiosmotic coupling (R-MMU-163210),4,-,6.86E-01,8.26E-01,9.41E-01,,,,,,,
Cristae formation (R-MMU-8949613),4,-,6.84E-01,8.29E-01,9.47E-01,,,,,,,
Mitochondrial biogenesis (R-MMU-1592230),4,-,6.83E-01,8.54E-01,9.52E-01,,,,,,,
Biological oxidations (R-MMU-211859),4,+,6.89E-01,8.74E-01,9.51E-01,,,,,,,
Phase I - Functionalization of compounds (R-MMU-211945),4,+,6.88E-01,8.73E-01,9.54E-01,,,,,,,
Factors involved in megakaryocyte development and platelet production (R-MMU-983231),4,+,6.94E-01,8.79E-01,9.50E-01,,,,,,,
Platelet Aggregation (Plug Formation) (R-MMU-76009),4,+,6.96E-01,8.78E-01,9.58E-01,,,,,,,
Protein methylation (R-MMU-8876725),4,-,7.09E-01,8.76E-01,9.61E-01,,,,,,,
Toll Like Receptor 9 (TLR9) Cascade (R-MMU-168138),4,-,7.50E-01,9.20E-01,9.64E-01,,,,,,,
Cell surface interactions at the vascular wall (R-MMU-202733),4,-,7.80E-01,9.19E-01,9.60E-01,,,,,,,
Pyruvate metabolism and Citric Acid (TCA) cycle (R-MMU-71406),4,+,7.97E-01,9.26E-01,9.72E-01,,,,,,,
SUMOylation (R-MMU-2990846),4,-,8.07E-01,9.25E-01,9.82E-01,,,,,,,
SUMO E3 ligases SUMOylate target proteins (R-MMU-3108232),4,-,8.06E-01,9.61E-01,9.79E-01,,,,,,,
"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways (R-MMU-168643)",4,-,8.82E-01,9.68E-01,9.98E-01,,,,,,,
Fatty acid metabolism (R-MMU-8978868),4,-,9.19E-01,9.83E-01,9.93E-01,,,,,,,
RNA Polymerase I Transcription (R-MMU-73864),4,-,9.27E-01,9.88E-01,9.92E-01,,,,,,,
Epigenetic regulation of gene expression (R-MMU-212165),4,+,9.37E-01,9.89E-01,9.94E-01,,,,,,,
Caspase-mediated cleavage of cytoskeletal proteins (R-MMU-264870),4,+,9.39E-01,9.88E-01,9.93E-01,,,,,,,
Regulation of mitotic cell cycle (R-MMU-453276),3,-,1.74E+00,5.29E+00,1.72E+00,,,,,,,
Regulation of APC/C activators between G1/S and early anaphase (R-MMU-176408),3,-,1.63E+00,4.31E+00,1.89E+00,,,,,,,
Regulation of RUNX2 expression and activity (R-MMU-8939902),3,-,1.53E+00,2.45E+00,1.82E+00,,,,,,,
Downstream signaling events of B Cell Receptor (BCR) (R-MMU-1168372),3,-,1.45E+00,2.30E+00,1.76E+00,,,,,,,
Downstream TCR signaling (R-MMU-202424),3,-,1.37E+00,2.16E+00,1.77E+00,,,,,,,
SCF(Skp2)-mediated degradation of p27/p21 (R-MMU-187577),3,-,1.30E+00,2.20E+00,1.72E+00,,,,,,,
Fc epsilon receptor (FCERI) signaling (R-MMU-2454202),3,-,1.24E+00,2.35E+00,1.33E+00,,,,,,,
TCR signaling (R-MMU-202403),3,-,1.18E+00,9.37E-01,1.37E+00,,,,,,,
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis (R-MMU-8854050),3,-,1.13E+00,9.27E-01,1.35E+00,,,,,,,
S Phase (R-MMU-69242),3,-,1.09E+00,9.17E-01,1.34E+00,,,,,,,
Degradation of beta-catenin by the destruction complex (R-MMU-195253),3,-,1.04E+00,9.07E-01,1.33E+00,,,,,,,
Synthesis of DNA (R-MMU-69239),3,-,1.00E+00,8.97E-01,1.31E+00,,,,,,,
Orc1 removal from chromatin (R-MMU-68949),3,-,9.65E-01,8.88E-01,1.30E+00,,,,,,,
G1/S Transition (R-MMU-69206),3,-,9.31E-01,8.79E-01,1.29E+00,,,,,,,
Cyclin E associated events during G1/S transition  (R-MMU-69202),3,-,8.99E-01,8.70E-01,1.27E+00,,,,,,,
Dectin-1 mediated noncanonical NF-kB signaling (R-MMU-5607761),3,-,8.69E-01,8.61E-01,1.26E+00,,,,,,,
TNFR2 non-canonical NF-kB pathway (R-MMU-5668541),3,-,8.41E-01,8.52E-01,1.25E+00,,,,,,,
Activation of NF-kappaB in B cells (R-MMU-1169091),3,-,8.14E-01,8.44E-01,1.24E+00,,,,,,,
NIK-->noncanonical NF-kB signaling (R-MMU-5676590),3,-,7.90E-01,8.35E-01,1.22E+00,,,,,,,
Switching of origins to a post-replicative state (R-MMU-69052),3,-,7.66E-01,8.27E-01,1.21E+00,,,,,,,
GLI3 is processed to GLI3R by the proteasome (R-MMU-5610785),3,-,7.44E-01,8.19E-01,1.20E+00,,,,,,,
Degradation of GLI1 by the proteasome (R-MMU-5610780),3,-,7.24E-01,8.11E-01,1.22E+00,,,,,,,
APC/C-mediated degradation of cell cycle proteins (R-MMU-174143),3,-,7.04E-01,8.03E-01,1.17E+00,,,,,,,
FCERI mediated NF-kB activation (R-MMU-2871837),3,-,6.86E-01,7.96E-01,1.15E+00,,,,,,,
Transcriptional regulation by RUNX2 (R-MMU-8878166),3,-,6.68E-01,7.88E-01,1.14E+00,,,,,,,
SCF-beta-TrCP mediated degradation of Emi1 (R-MMU-174113),3,-,6.51E-01,7.81E-01,1.14E+00,,,,,,,
DNA Replication (R-MMU-69306),3,-,6.36E-01,7.74E-01,1.13E+00,,,,,,,
Cyclin A:Cdk2-associated events at S phase entry (R-MMU-69656),3,-,6.20E-01,7.67E-01,1.12E+00,,,,,,,
Cargo recognition for clathrin-mediated endocytosis (R-MMU-8856825),3,-,7.25E-01,7.60E-01,1.11E+00,,,,,,,
Hedgehog 'on' state (R-MMU-5632684),3,-,4.60E-01,7.53E-01,1.10E+00,,,,,,,
NCAM signaling for neurite out-growth (R-MMU-375165),3,+,5.17E-01,7.46E-01,1.10E+00,,,,,,,
Ion channel transport (R-MMU-983712),3,-,5.30E-01,7.40E-01,1.09E+00,,,,,,,
MyD88 dependent cascade initiated on endosome (R-MMU-975155),3,-,5.92E-01,7.34E-01,1.08E+00,,,,,,,
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation (R-MMU-975138),3,-,5.87E-01,7.27E-01,1.08E+00,,,,,,,
MyD88:Mal cascade initiated on plasma membrane (R-MMU-166058),3,-,5.83E-01,7.21E-01,1.07E+00,,,,,,,
Toll Like Receptor 4 (TLR4) Cascade (R-MMU-166016),3,-,5.79E-01,7.22E-01,1.06E+00,,,,,,,
TRIF(TICAM1)-mediated TLR4 signaling  (R-MMU-937061),3,-,5.74E-01,7.47E-01,1.06E+00,,,,,,,
Toll Like Receptor 2 (TLR2) Cascade (R-MMU-181438),3,-,5.70E-01,8.24E-01,1.05E+00,,,,,,,
MyD88-independent TLR4 cascade  (R-MMU-166166),3,-,5.66E-01,8.06E-01,1.04E+00,,,,,,,
MyD88 cascade initiated on plasma membrane (R-MMU-975871),3,-,5.62E-01,8.09E-01,1.04E+00,,,,,,,
Toll Like Receptor TLR6:TLR2 Cascade (R-MMU-168188),3,-,5.58E-01,8.32E-01,1.03E+00,,,,,,,
Toll Like Receptor 7/8 (TLR7/8) Cascade (R-MMU-168181),3,-,5.54E-01,8.51E-01,1.02E+00,,,,,,,
Toll Like Receptor TLR1:TLR2 Cascade (R-MMU-168179),3,-,5.50E-01,8.47E-01,1.02E+00,,,,,,,
Toll Like Receptor 5 (TLR5) Cascade (R-MMU-168176),3,-,5.46E-01,8.47E-01,1.01E+00,,,,,,,
Toll Like Receptor 3 (TLR3) Cascade (R-MMU-168164),3,-,5.42E-01,8.60E-01,1.01E+00,,,,,,,
Toll Like Receptor 10 (TLR10) Cascade (R-MMU-168142),3,-,5.38E-01,8.83E-01,9.99E-01,,,,,,,
Intracellular signaling by second messengers (R-MMU-9006925),3,-,5.64E-01,9.06E-01,9.93E-01,,,,,,,
PIP3 activates AKT signaling (R-MMU-1257604),3,-,5.61E-01,9.02E-01,9.87E-01,,,,,,,
PTEN Regulation (R-MMU-6807070),3,-,5.59E-01,8.99E-01,9.81E-01,,,,,,,
Metabolism of vitamins and cofactors (R-MMU-196854),3,-,5.97E-01,8.95E-01,9.76E-01,,,,,,,
Metabolism of polyamines (R-MMU-351202),3,-,5.90E-01,8.92E-01,9.70E-01,,,,,,,
Signaling by MET (R-MMU-6806834),3,-,6.13E-01,8.88E-01,7.61E-01,,,,,,,
Plasma lipoprotein remodeling (R-MMU-8963899),3,-,6.14E-01,8.85E-01,7.78E-01,,,,,,,
FGFR2 alternative splicing (R-MMU-6803529),3,-,6.11E-01,8.81E-01,7.82E-01,,,,,,,
Gap junction trafficking and regulation (R-MMU-157858),3,-,6.50E-01,8.78E-01,7.79E-01,,,,,,,
Gap junction trafficking (R-MMU-190828),3,-,6.47E-01,8.74E-01,8.00E-01,,,,,,,
Interaction between L1 and Ankyrins (R-MMU-445095),3,+,5.51E-01,8.71E-01,8.13E-01,,,,,,,
Antigen processing-Cross presentation (R-MMU-1236975),3,-,5.54E-01,8.67E-01,8.10E-01,,,,,,,
Apoptotic cleavage of cell adhesion  proteins (R-MMU-351906),3,+,5.68E-01,8.64E-01,8.08E-01,,,,,,,
Signaling by ROBO receptors (R-MMU-376176),3,+,5.68E-01,8.61E-01,8.33E-01,,,,,,,
MAPK6/MAPK4 signaling (R-MMU-5687128),3,-,5.82E-01,8.58E-01,8.32E-01,,,,,,,
Global Genome Nucleotide Excision Repair (GG-NER) (R-MMU-5696399),3,-,5.81E-01,8.78E-01,8.29E-01,,,,,,,
Nucleotide Excision Repair (R-MMU-5696398),3,-,5.79E-01,8.81E-01,8.26E-01,,,,,,,
DNA Damage Recognition in GG-NER (R-MMU-5696394),3,-,5.78E-01,8.78E-01,8.35E-01,,,,,,,
Plasma lipoprotein clearance (R-MMU-8964043),3,-,6.93E-01,8.94E-01,7.94E-01,,,,,,,
Semaphorin interactions (R-MMU-373755),3,+,7.11E-01,7.98E-01,7.92E-01,,,,,,,
Senescence-Associated Secretory Phenotype (SASP) (R-MMU-2559582),3,-,7.18E-01,8.02E-01,8.02E-01,,,,,,,
GP1b-IX-V activation signalling (R-MMU-430116),3,-,7.35E-01,8.00E-01,8.17E-01,,,,,,,
Synthesis of active ubiquitin: roles of E1 and E2 enzymes (R-MMU-8866652),3,-,8.09E-01,7.98E-01,8.22E-01,,,,,,,
Protein ubiquitination (R-MMU-8852135),3,-,8.07E-01,7.97E-01,8.20E-01,,,,,,,
Metabolism of steroids (R-MMU-8957322),3,-,8.33E-01,7.95E-01,8.18E-01,,,,,,,
Transcriptional regulation by small RNAs (R-MMU-5578749),3,-,8.57E-01,7.93E-01,8.16E-01,,,,,,,
Gene Silencing by RNA (R-MMU-211000),3,-,8.55E-01,7.92E-01,8.15E-01,,,,,,,
Trafficking and processing of endosomal TLR (R-MMU-1679131),3,+,8.84E-01,7.90E-01,8.13E-01,,,,,,,
Glycogen metabolism (R-MMU-8982491),3,-,8.81E-01,8.05E-01,8.11E-01,,,,,,,
Plasma lipoprotein assembly (R-MMU-8963898),3,-,8.84E-01,8.03E-01,8.13E-01,,,,,,,
Chylomicron assembly (R-MMU-8963888),3,-,8.82E-01,8.12E-01,8.34E-01,,,,,,,
Regulation of TP53 Activity (R-MMU-5633007),3,+,9.01E-01,8.10E-01,8.32E-01,,,,,,,
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell (R-MMU-198933),3,-,9.09E-01,8.52E-01,8.48E-01,,,,,,,
Signaling by Retinoic Acid (R-MMU-5362517),3,+,9.21E-01,8.76E-01,8.46E-01,,,,,,,
Scavenging by Class A Receptors (R-MMU-3000480),3,-,9.28E-01,8.74E-01,8.44E-01,,,,,,,
Neuronal System (R-MMU-112316),3,-,9.31E-01,8.61E-01,8.85E-01,,,,,,,
Transmission across Chemical Synapses (R-MMU-112315),3,-,9.29E-01,8.72E-01,9.33E-01,,,,,,,
Inflammasomes (R-MMU-622312),3,+,9.38E-01,8.71E-01,9.40E-01,,,,,,,
The NLRP3 inflammasome (R-MMU-844456),3,+,9.37E-01,8.69E-01,9.38E-01,,,,,,,
DNA Damage/Telomere Stress Induced Senescence (R-MMU-2559586),3,+,9.43E-01,8.67E-01,9.51E-01,,,,,,,
Signaling by VEGF (R-MMU-194138),3,+,9.60E-01,8.66E-01,9.42E-01,,,,,,,
VEGFA-VEGFR2 Pathway (R-MMU-4420097),3,+,9.59E-01,8.64E-01,9.40E-01,,,,,,,
Nucleosome assembly (R-MMU-774815),3,+,9.60E-01,8.72E-01,9.43E-01,,,,,,,
Deposition of new CENPA-containing nucleosomes at the centromere (R-MMU-606279),3,+,9.59E-01,8.71E-01,9.42E-01,,,,,,,
Chromatin organization (R-MMU-4839726),3,+,9.57E-01,8.92E-01,9.40E-01,,,,,,,
PRC2 methylates histones and DNA (R-MMU-212300),3,+,9.56E-01,8.91E-01,9.42E-01,,,,,,,
Chromosome Maintenance (R-MMU-73886),3,+,9.54E-01,9.25E-01,9.53E-01,,,,,,,
Chromatin modifying enzymes (R-MMU-3247509),3,+,9.53E-01,9.82E-01,9.51E-01,,,,,,,
RNA Polymerase I Promoter Clearance (R-MMU-73854),3,+,9.51E-01,9.81E-01,9.58E-01,,,,,,,
Death Receptor Signalling (R-MMU-73887),3,-,9.73E-01,9.80E-01,9.63E-01,,,,,,,
B-WICH complex positively regulates rRNA expression (R-MMU-5250924),3,+,9.83E-01,9.86E-01,9.61E-01,,,,,,,
Positive epigenetic regulation of rRNA expression (R-MMU-5250913),3,+,9.82E-01,9.85E-01,9.76E-01,,,,,,,
Kinesins (R-MMU-983189),3,+,1.01E+00,9.83E-01,9.77E-01,,,,,,,
COPI-dependent Golgi-to-ER retrograde traffic (R-MMU-6811434),3,+,1.01E+00,9.91E-01,9.81E-01,,,,,,,
"Antigen Presentation: Folding, assembly and peptide loading of class I MHC (R-MMU-983170)",3,-,1.01E+00,9.89E-01,9.97E-01,,,,,,,
Metabolism of nucleotides (R-MMU-15869),3,+,9.97E-01,9.88E-01,9.95E-01,,,,,,,
G2/M DNA damage checkpoint (R-MMU-69473),3,0,1.00E+00,9.92E-01,9.93E-01,,,,,,,
GPCR ligand binding (R-MMU-500792),3,0,1.00E+00,9.90E-01,9.98E-01,,,,,,,
Peptide ligand-binding receptors (R-MMU-375276),3,0,1.00E+00,9.83E-01,9.98E-01,,,,,,,
Class A/1 (Rhodopsin-like receptors) (R-MMU-373076),3,0,1.00E+00,9.95E-01,9.97E-01,,,,,,,
"Gamma carboxylation, hypusine formation and arylsulfatase activation (R-MMU-163841)",2,-,2.22E+00,4.98E+00,2.06E+00,,,,,,,
Stimuli-sensing channels (R-MMU-2672351),2,-,7.29E-01,2.59E+00,1.93E+00,,,,,,,
DNA Double Strand Break Response (R-MMU-5693606),2,-,7.37E-01,2.41E+00,2.35E+00,,,,,,,
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks (R-MMU-5693565),2,-,7.22E-01,2.53E+00,2.22E+00,,,,,,,
DNA Double-Strand Break Repair (R-MMU-5693532),2,-,7.08E-01,2.43E+00,2.10E+00,,,,,,,
G1/S DNA Damage Checkpoints (R-MMU-69615),2,-,7.31E-01,1.66E+00,2.00E+00,,,,,,,
p53-Independent G1/S DNA damage checkpoint (R-MMU-69613),2,-,7.17E-01,1.62E+00,1.90E+00,,,,,,,
p53-Independent DNA Damage Response (R-MMU-69610),2,-,7.04E-01,1.58E+00,1.82E+00,,,,,,,
Autodegradation of the E3 ubiquitin ligase COP1 (R-MMU-349425),2,-,6.91E-01,1.56E+00,1.56E+00,,,,,,,
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A (R-MMU-69601),2,-,6.79E-01,1.49E+00,1.53E+00,,,,,,,
M/G1 Transition (R-MMU-68874),2,-,6.67E-01,1.46E+00,1.49E+00,,,,,,,
Assembly of the pre-replicative complex (R-MMU-68867),2,-,6.55E-01,1.43E+00,1.46E+00,,,,,,,
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha (R-MMU-1234176),2,-,6.44E-01,1.41E+00,1.34E+00,,,,,,,
Regulation of Hypoxia-inducible Factor (HIF) by oxygen (R-MMU-1234174),2,-,6.33E-01,1.39E+00,1.32E+00,,,,,,,
Regulation of PTEN stability and activity (R-MMU-8948751),2,-,6.23E-01,1.36E+00,1.29E+00,,,,,,,
CDT1 association with the CDC6:ORC:origin complex (R-MMU-68827),2,-,6.13E-01,1.34E+00,1.43E+00,,,,,,,
Cellular response to hypoxia (R-MMU-2262749),2,-,6.03E-01,1.32E+00,1.41E+00,,,,,,,
APC/C:Cdc20 mediated degradation of mitotic proteins (R-MMU-176409),2,-,5.94E-01,1.30E+00,1.39E+00,,,,,,,
Autodegradation of Cdh1 by Cdh1:APC/C (R-MMU-174084),2,-,5.85E-01,1.28E+00,1.37E+00,,,,,,,
Regulation of RUNX3 expression and activity (R-MMU-8941858),2,-,5.76E-01,1.26E+00,1.35E+00,,,,,,,
Ubiquitin-dependent degradation of Cyclin D1 (R-MMU-69229),2,-,5.67E-01,1.24E+00,1.32E+00,,,,,,,
p53-Dependent G1/S DNA damage checkpoint (R-MMU-69580),2,-,5.59E-01,1.22E+00,1.37E+00,,,,,,,
RUNX1 regulates transcription of genes involved in differentiation of HSCs (R-MMU-8939236),2,-,5.51E-01,1.20E+00,1.18E+00,,,,,,,
p53-Dependent G1 DNA Damage Response (R-MMU-69563),2,-,5.43E-01,1.18E+00,1.17E+00,,,,,,,
Stabilization of p53 (R-MMU-69541),2,-,5.35E-01,1.16E+00,1.16E+00,,,,,,,
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins (R-MMU-176814),2,-,5.28E-01,1.15E+00,9.67E-01,,,,,,,
Cdc20:Phospho-APC/C mediated degradation of Cyclin A (R-MMU-174184),2,-,5.21E-01,1.13E+00,9.62E-01,,,,,,,
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 (R-MMU-174178),2,-,5.13E-01,1.12E+00,7.20E-01,,,,,,,
Ubiquitin-dependent degradation of Cyclin D (R-MMU-75815),2,-,5.07E-01,1.10E+00,8.08E-01,,,,,,,
CDK-mediated phosphorylation and removal of Cdc6 (R-MMU-69017),2,-,5.00E-01,1.09E+00,8.06E-01,,,,,,,
APC/C:Cdc20 mediated degradation of Securin (R-MMU-174154),2,-,4.93E-01,1.07E+00,8.03E-01,,,,,,,
DNA Replication Pre-Initiation (R-MMU-69002),2,-,4.87E-01,1.06E+00,8.09E-01,,,,,,,
Asymmetric localization of PCP proteins (R-MMU-4608870),2,-,4.81E-01,1.04E+00,8.06E-01,,,,,,,
Regulation of RAS by GAPs (R-MMU-5658442),2,-,4.75E-01,1.03E+00,8.03E-01,,,,,,,
Transcriptional regulation by RUNX3 (R-MMU-8878159),2,-,4.69E-01,1.02E+00,8.37E-01,,,,,,,
Degradation of DVL (R-MMU-4641258),2,-,4.63E-01,1.00E+00,8.34E-01,,,,,,,
Degradation of AXIN (R-MMU-4641257),2,-,4.58E-01,9.92E-01,8.35E-01,,,,,,,
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint (R-MMU-179419),2,-,4.52E-01,9.80E-01,8.33E-01,,,,,,,
Ub-specific processing proteases (R-MMU-5689880),2,-,4.47E-01,9.68E-01,8.30E-01,,,,,,,
p130Cas linkage to MAPK signaling for integrins (R-MMU-372708),2,+,5.39E-01,9.57E-01,8.39E-01,,,,,,,
GRB2:SOS provides linkage to MAPK signaling for Integrins  (R-MMU-354194),2,+,5.34E-01,9.45E-01,8.36E-01,,,,,,,
Integrin alphaIIb beta3 signaling (R-MMU-354192),2,+,5.28E-01,9.34E-01,8.34E-01,,,,,,,
Integrin signaling (R-MMU-9006921),2,+,5.22E-01,9.24E-01,8.19E-01,,,,,,,
SUMOylation of chromatin organization proteins (R-MMU-4551638),2,-,5.96E-01,7.98E-01,8.16E-01,,,,,,,
SLC-mediated transmembrane transport (R-MMU-425407),2,-,5.44E-01,8.29E-01,8.14E-01,,,,,,,
NOTCH3 Activation and Transmission of Signal to the Nucleus (R-MMU-9013507),2,-,5.95E-01,8.24E-01,8.59E-01,,,,,,,
Signaling by NOTCH (R-MMU-157118),2,-,5.91E-01,8.18E-01,8.57E-01,,,,,,,
Signaling by NOTCH3 (R-MMU-9012852),2,-,5.87E-01,8.13E-01,8.54E-01,,,,,,,
Clathrin derived vesicle budding (R-MMU-421837),2,-,5.92E-01,8.07E-01,8.52E-01,,,,,,,
trans-Golgi Network Vesicle Budding (R-MMU-199992),2,-,5.89E-01,8.42E-01,8.50E-01,,,,,,,
Golgi Associated Vesicle Biogenesis (R-MMU-432722),2,-,5.85E-01,8.37E-01,8.47E-01,,,,,,,
Lysosome Vesicle Biogenesis (R-MMU-432720),2,-,5.82E-01,8.32E-01,8.45E-01,,,,,,,
Signaling by ERBB2 (R-MMU-1227986),2,-,5.77E-01,8.27E-01,8.43E-01,,,,,,,
Downregulation of ERBB2 signaling (R-MMU-8863795),2,-,5.74E-01,8.14E-01,8.40E-01,,,,,,,
Translesion Synthesis by POLH (R-MMU-110320),2,-,5.79E-01,8.34E-01,8.38E-01,,,,,,,
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template (R-MMU-110313),2,-,5.75E-01,8.30E-01,8.36E-01,,,,,,,
DNA Damage Bypass (R-MMU-73893),2,-,5.72E-01,8.25E-01,8.33E-01,,,,,,,
Ovarian tumor domain proteases (R-MMU-5689896),2,-,5.69E-01,8.21E-01,8.31E-01,,,,,,,
Triglyceride metabolism (R-MMU-8979227),2,-,5.71E-01,8.26E-01,8.29E-01,,,,,,,
Triglyceride catabolism (R-MMU-163560),2,-,5.68E-01,8.22E-01,8.27E-01,,,,,,,
MAP kinase activation (R-MMU-450294),2,-,5.77E-01,8.18E-01,8.24E-01,,,,,,,
G1 Phase (R-MMU-69236),2,-,5.74E-01,8.46E-01,8.22E-01,,,,,,,
Cyclin D associated events in G1 (R-MMU-69231),2,-,5.71E-01,8.42E-01,8.20E-01,,,,,,,
Interleukin-17 signaling (R-MMU-448424),2,-,5.68E-01,8.39E-01,8.18E-01,,,,,,,
MAP3K8 (TPL2)-dependent MAPK1/3 activation (R-MMU-5684264),2,-,5.65E-01,8.35E-01,8.16E-01,,,,,,,
Ion homeostasis (R-MMU-5578775),2,-,5.71E-01,8.31E-01,8.13E-01,,,,,,,
Cardiac conduction (R-MMU-5576891),2,-,5.68E-01,8.28E-01,8.11E-01,,,,,,,
Formation of Incision Complex in GG-NER (R-MMU-5696395),2,-,5.94E-01,8.24E-01,8.09E-01,,,,,,,
TAK1 activates NFkB by phosphorylation and activation of IKKs complex (R-MMU-445989),2,-,5.99E-01,8.42E-01,8.07E-01,,,,,,,
DDX58/IFIH1-mediated induction of interferon-alpha/beta (R-MMU-168928),2,-,5.97E-01,8.38E-01,8.05E-01,,,,,,,
Cytosolic sensors of pathogen-associated DNA  (R-MMU-1834949),2,-,5.94E-01,8.67E-01,8.03E-01,,,,,,,
Activation of BAD and translocation to mitochondria  (R-MMU-111447),2,+,6.77E-01,8.90E-01,8.01E-01,,,,,,,
Intrinsic Pathway for Apoptosis (R-MMU-109606),2,+,6.75E-01,8.95E-01,7.99E-01,,,,,,,
Translocation of SLC2A4 (GLUT4) to the plasma membrane (R-MMU-1445148),2,+,6.72E-01,8.92E-01,7.96E-01,,,,,,,
TNF signaling (R-MMU-75893),2,-,6.69E-01,8.89E-01,7.94E-01,,,,,,,
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex (R-MMU-75035),2,+,6.67E-01,8.86E-01,7.92E-01,,,,,,,
Activation of BH3-only proteins (R-MMU-114452),2,+,6.64E-01,8.83E-01,7.90E-01,,,,,,,
TNFR1-induced NFkappaB signaling pathway (R-MMU-5357956),2,-,6.62E-01,8.80E-01,7.88E-01,,,,,,,
Regulation of TNFR1 signaling (R-MMU-5357905),2,-,6.59E-01,8.77E-01,7.86E-01,,,,,,,
Aryl hydrocarbon receptor signalling (R-MMU-8937144),2,+,6.84E-01,8.92E-01,7.88E-01,,,,,,,
Formation of annular gap junctions (R-MMU-196025),2,-,5.70E-01,8.89E-01,7.97E-01,,,,,,,
Gap junction degradation (R-MMU-190873),2,-,5.69E-01,8.86E-01,7.95E-01,,,,,,,
Glyoxylate metabolism and glycine degradation (R-MMU-389661),2,+,5.69E-01,8.87E-01,7.93E-01,,,,,,,
Regulation of pyruvate dehydrogenase (PDH) complex (R-MMU-204174),2,+,5.67E-01,8.84E-01,7.91E-01,,,,,,,
Pyruvate metabolism (R-MMU-70268),2,+,5.66E-01,8.82E-01,7.89E-01,,,,,,,
Chondroitin sulfate/dermatan sulfate metabolism (R-MMU-1793185),2,+,5.74E-01,8.95E-01,7.87E-01,,,,,,,
Dermatan sulfate biosynthesis (R-MMU-2022923),2,+,5.73E-01,8.93E-01,7.85E-01,,,,,,,
Heparan sulfate/heparin (HS-GAG) metabolism (R-MMU-1638091),2,+,5.71E-01,8.90E-01,7.93E-01,,,,,,,
CS/DS degradation (R-MMU-2024101),2,+,5.70E-01,8.87E-01,7.91E-01,,,,,,,
A tetrasaccharide linker sequence is required for GAG synthesis (R-MMU-1971475),2,+,5.68E-01,8.85E-01,7.89E-01,,,,,,,
HDL remodeling (R-MMU-8964058),2,-,5.67E-01,8.99E-01,7.99E-01,,,,,,,
Chondroitin sulfate biosynthesis (R-MMU-2022870),2,+,5.65E-01,9.12E-01,8.20E-01,,,,,,,
mRNA Splicing - Minor Pathway (R-MMU-72165),2,-,5.85E-01,9.26E-01,8.18E-01,,,,,,,
Mitochondrial Fatty Acid Beta-Oxidation (R-MMU-77289),2,-,5.84E-01,9.29E-01,8.16E-01,,,,,,,
PKMTs methylate histone lysines (R-MMU-3214841),2,-,5.85E-01,9.28E-01,8.47E-01,,,,,,,
HDACs deacetylate histones (R-MMU-3214815),2,-,5.84E-01,9.34E-01,8.70E-01,,,,,,,
Visual phototransduction (R-MMU-2187338),2,-,5.99E-01,9.32E-01,8.81E-01,,,,,,,
Metabolism of fat-soluble vitamins (R-MMU-6806667),2,-,5.97E-01,9.29E-01,8.80E-01,,,,,,,
Chylomicron remodeling (R-MMU-8963901),2,-,5.96E-01,7.88E-01,8.82E-01,,,,,,,
Retinoid metabolism and transport (R-MMU-975634),2,-,5.95E-01,7.93E-01,8.83E-01,,,,,,,
SUMOylation of transcription cofactors (R-MMU-3899300),2,+,5.91E-01,7.92E-01,9.18E-01,,,,,,,
Non-integrin membrane-ECM interactions (R-MMU-3000171),2,-,6.92E-01,7.90E-01,9.31E-01,,,,,,,
MET activates PTK2 signaling (R-MMU-8874081),2,-,6.90E-01,7.88E-01,9.50E-01,,,,,,,
Anchoring fibril formation (R-MMU-2214320),2,-,6.89E-01,7.99E-01,9.48E-01,,,,,,,
Platelet Adhesion to exposed collagen (R-MMU-75892),2,-,6.87E-01,7.99E-01,9.46E-01,,,,,,,
GPVI-mediated activation cascade (R-MMU-114604),2,-,6.86E-01,7.98E-01,9.44E-01,,,,,,,
MET promotes cell motility (R-MMU-8875878),2,-,6.84E-01,7.96E-01,9.52E-01,,,,,,,
Crosslinking of collagen fibrils (R-MMU-2243919),2,-,6.82E-01,8.11E-01,9.50E-01,,,,,,,
Regulation of Complement cascade (R-MMU-977606),2,-,6.88E-01,8.09E-01,9.48E-01,,,,,,,
Transport of Mature mRNA derived from an Intron-Containing Transcript (R-MMU-159236),2,-,6.86E-01,8.11E-01,9.46E-01,,,,,,,
Initial triggering of complement (R-MMU-166663),2,-,6.85E-01,8.10E-01,9.50E-01,,,,,,,
Complement cascade (R-MMU-166658),2,-,6.83E-01,8.08E-01,9.48E-01,,,,,,,
Transport of Mature Transcript to Cytoplasm (R-MMU-72202),2,-,6.82E-01,8.34E-01,9.46E-01,,,,,,,
Type I hemidesmosome assembly (R-MMU-446107),2,+,7.50E-01,8.32E-01,9.45E-01,,,,,,,
Arachidonic acid metabolism (R-MMU-2142753),2,+,7.48E-01,8.30E-01,9.43E-01,,,,,,,
EPHB-mediated forward signaling (R-MMU-3928662),2,-,7.89E-01,8.29E-01,9.41E-01,,,,,,,
EPH-Ephrin signaling (R-MMU-2682334),2,-,7.88E-01,8.27E-01,9.39E-01,,,,,,,
Creatine metabolism (R-MMU-71288),2,-,8.33E-01,8.73E-01,9.37E-01,,,,,,,
Keratan sulfate/keratin metabolism (R-MMU-1638074),2,+,8.41E-01,8.72E-01,9.36E-01,,,,,,,
Keratan sulfate degradation (R-MMU-2022857),2,+,8.39E-01,8.70E-01,9.34E-01,,,,,,,
Keratan sulfate biosynthesis (R-MMU-2022854),2,+,8.38E-01,8.68E-01,9.32E-01,,,,,,,
Peroxisomal protein import (R-MMU-9033241),2,-,8.43E-01,8.67E-01,9.30E-01,,,,,,,
Regulation of TLR by endogenous ligand (R-MMU-5686938),2,+,8.62E-01,8.65E-01,9.43E-01,,,,,,,
G alpha (q) signalling events (R-MMU-416476),2,-,8.80E-01,8.77E-01,9.45E-01,,,,,,,
Glycogen synthesis (R-MMU-3322077),2,+,8.83E-01,8.75E-01,9.44E-01,,,,,,,
Signaling by TGF-beta Receptor Complex (R-MMU-170834),2,+,8.87E-01,8.74E-01,9.42E-01,,,,,,,
Signaling by TGF-beta family members (R-MMU-9006936),2,+,8.85E-01,8.86E-01,9.40E-01,,,,,,,
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) (R-MMU-2173791),2,+,8.84E-01,8.84E-01,9.38E-01,,,,,,,
Glycogen breakdown (glycogenolysis) (R-MMU-70221),2,+,8.95E-01,9.00E-01,9.37E-01,,,,,,,
Citric acid cycle (TCA cycle) (R-MMU-71403),2,-,9.21E-01,9.07E-01,9.42E-01,,,,,,,
HDL clearance (R-MMU-8964011),2,+,9.27E-01,9.17E-01,9.51E-01,,,,,,,
rRNA processing (R-MMU-72312),2,+,9.23E-01,9.23E-01,9.57E-01,,,,,,,
Major pathway of rRNA processing in the nucleolus and cytosol (R-MMU-6791226),2,+,9.21E-01,9.47E-01,9.48E-01,,,,,,,
rRNA processing in the nucleus and cytosol (R-MMU-8868773),2,+,9.20E-01,9.67E-01,9.47E-01,,,,,,,
p75 NTR receptor-mediated signalling (R-MMU-193704),2,+,9.16E-01,9.66E-01,9.50E-01,,,,,,,
"Cell death signalling via NRAGE, NRIF and NADE (R-MMU-204998)",2,+,9.14E-01,9.71E-01,9.55E-01,,,,,,,
Negative regulation of MAPK pathway (R-MMU-5675221),2,-,9.36E-01,9.79E-01,9.54E-01,,,,,,,
Nuclear Envelope Breakdown (R-MMU-2980766),2,-,9.33E-01,9.74E-01,9.63E-01,,,,,,,
ER-Phagosome pathway (R-MMU-1236974),2,-,9.37E-01,9.81E-01,9.61E-01,,,,,,,
Formation of Fibrin Clot (Clotting Cascade) (R-MMU-140877),2,+,9.60E-01,9.80E-01,9.60E-01,,,,,,,
Molecules associated with elastic fibres (R-MMU-2129379),2,+,9.60E-01,9.88E-01,9.58E-01,,,,,,,
HuR (ELAVL1) binds and stabilizes mRNA (R-MMU-450520),2,+,9.59E-01,9.86E-01,9.56E-01,,,,,,,
Elastic fibre formation (R-MMU-1566948),2,+,9.58E-01,9.91E-01,9.75E-01,,,,,,,
RNA Polymerase I Chain Elongation (R-MMU-73777),2,-,1.01E+00,9.92E-01,9.80E-01,,,,,,,
RNA Polymerase I Promoter Opening (R-MMU-73728),2,-,1.01E+00,9.90E-01,9.79E-01,,,,,,,
NoRC negatively regulates rRNA expression (R-MMU-427413),2,-,1.01E+00,9.89E-01,9.78E-01,,,,,,,
Telomere Maintenance (R-MMU-157579),2,-,1.00E+00,9.87E-01,9.97E-01,,,,,,,
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 (R-MMU-5625886),2,-,1.00E+00,9.86E-01,9.96E-01,,,,,,,
Condensation of Prophase Chromosomes (R-MMU-2299718),2,-,1.00E+00,9.84E-01,9.94E-01,,,,,,,
RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function (R-MMU-8936459),2,-,9.99E-01,9.83E-01,9.97E-01,,,,,,,
RMTs methylate histone arginines (R-MMU-3214858),2,-,9.98E-01,9.82E-01,9.97E-01,,,,,,,
Negative epigenetic regulation of rRNA expression (R-MMU-5250941),2,-,9.97E-01,9.80E-01,9.95E-01,,,,,,,
SIRT1 negatively regulates rRNA expression (R-MMU-427359),2,-,9.95E-01,9.79E-01,9.94E-01,,,,,,,
Packaging Of Telomere Ends (R-MMU-171306),2,-,9.94E-01,9.77E-01,9.92E-01,,,,,,,
Formation of the beta-catenin:TCF transactivating complex (R-MMU-201722),2,-,9.92E-01,9.76E-01,9.98E-01,,,,,,,
Signaling by Non-Receptor Tyrosine Kinases (R-MMU-9006927),2,-,1.00E+00,9.82E-01,9.97E-01,,,,,,,
Signaling by PTK6 (R-MMU-8848021),2,-,1.00E+00,9.81E-01,9.96E-01,,,,,,,
Sema3A PAK dependent Axon repulsion (R-MMU-399954),2,-,1.00E+00,9.96E-01,9.94E-01,,,,,,,
Erythrocytes take up oxygen and release carbon dioxide (R-MMU-1247673),1,-,5.83E-01,2.41E+00,1.65E+00,,,,,,,
Erythrocytes take up carbon dioxide and release oxygen (R-MMU-1237044),1,-,5.78E-01,2.32E+00,1.61E+00,,,,,,,
O2/CO2 exchange in erythrocytes (R-MMU-1480926),1,-,5.72E-01,2.23E+00,1.64E+00,,,,,,,
Retrograde neurotrophin signalling (R-MMU-177504),1,-,6.29E-01,2.32E+00,1.60E+00,,,,,,,
Signaling by NTRKs (R-MMU-166520),1,-,6.23E-01,2.24E+00,1.56E+00,,,,,,,
WNT5A-dependent internalization of FZD4 (R-MMU-5099900),1,-,6.17E-01,2.17E+00,1.46E+00,,,,,,,
"WNT5A-dependent internalization of FZD2, FZD5 and ROR2 (R-MMU-5140745)",1,-,6.11E-01,2.15E+00,1.44E+00,,,,,,,
VLDLR internalisation and degradation (R-MMU-8866427),1,-,6.06E-01,2.08E+00,1.41E+00,,,,,,,
Signaling by NTRK1 (TRKA) (R-MMU-187037),1,-,6.01E-01,2.02E+00,1.38E+00,,,,,,,
LDL clearance (R-MMU-8964038),1,-,5.95E-01,1.96E+00,1.35E+00,,,,,,,
HATs acetylate histones (R-MMU-3214847),1,-,6.00E-01,1.91E+00,1.39E+00,,,,,,,
Nonhomologous End-Joining (NHEJ) (R-MMU-5693571),1,-,5.95E-01,1.86E+00,1.40E+00,,,,,,,
HDMs demethylate histones (R-MMU-3214842),1,-,5.90E-01,1.81E+00,1.37E+00,,,,,,,
Galactose catabolism (R-MMU-70370),1,+,5.85E-01,1.76E+00,1.35E+00,,,,,,,
Protein repair (R-MMU-5676934),1,-,5.93E-01,1.72E+00,1.32E+00,,,,,,,
Interconversion of nucleotide di- and triphosphates (R-MMU-499943),1,-,5.88E-01,1.56E+00,1.30E+00,,,,,,,
Classical antibody-mediated complement activation (R-MMU-173623),1,-,5.91E-01,1.53E+00,1.41E+00,,,,,,,
Role of phospholipids in phagocytosis (R-MMU-2029485),1,-,5.87E-01,1.54E+00,1.44E+00,,,,,,,
FCGR activation (R-MMU-2029481),1,-,5.82E-01,1.51E+00,1.42E+00,,,,,,,
Creation of C4 and C2 activators (R-MMU-166786),1,-,5.77E-01,9.26E-01,1.39E+00,,,,,,,
Cross-presentation of soluble exogenous antigens (endosomes) (R-MMU-1236978),1,-,5.85E-01,9.16E-01,1.33E+00,,,,,,,
Regulation of ornithine decarboxylase (ODC) (R-MMU-350562),1,-,5.81E-01,7.14E-01,1.31E+00,,,,,,,
Peptide chain elongation (R-MMU-156902),1,-,5.39E-01,7.08E-01,1.29E+00,,,,,,,
Synthesis of diphthamide-EEF2 (R-MMU-5358493),1,-,5.35E-01,7.02E-01,1.28E+00,,,,,,,
Eukaryotic Translation Elongation (R-MMU-156842),1,-,5.32E-01,6.97E-01,1.27E+00,,,,,,,
Hypusine synthesis from eIF5A-lysine (R-MMU-204626),1,-,5.36E-01,7.05E-01,1.31E+00,,,,,,,
Beta oxidation of octanoyl-CoA to hexanoyl-CoA (R-MMU-77348),1,-,6.00E-01,7.00E-01,1.35E+00,,,,,,,
Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA (R-MMU-77346),1,-,5.97E-01,6.94E-01,1.34E+00,,,,,,,
Rab regulation of trafficking (R-MMU-9007101),1,+,5.93E-01,7.58E-01,1.26E+00,,,,,,,
Signaling by Hippo (R-MMU-2028269),1,+,5.89E-01,7.52E-01,1.25E+00,,,,,,,
mitochondrial fatty acid beta-oxidation of unsaturated fatty acids (R-MMU-77288),1,-,5.86E-01,7.46E-01,1.24E+00,,,,,,,
mitochondrial fatty acid beta-oxidation of saturated fatty acids (R-MMU-77286),1,-,5.82E-01,7.41E-01,1.23E+00,,,,,,,
RAB GEFs exchange GTP for GDP on RABs (R-MMU-8876198),1,+,5.79E-01,8.28E-01,1.22E+00,,,,,,,
NADE modulates death signalling (R-MMU-205025),1,+,5.75E-01,8.20E-01,1.24E+00,,,,,,,
Purine ribonucleoside monophosphate biosynthesis (R-MMU-73817),1,+,5.80E-01,8.50E-01,1.23E+00,,,,,,,
Nucleobase biosynthesis (R-MMU-8956320),1,+,5.76E-01,8.45E-01,1.22E+00,,,,,,,
Regulation of TP53 Activity through Association with Co-factors (R-MMU-6804759),1,+,5.68E-01,8.30E-01,1.21E+00,,,,,,,
Signaling by PDGF (R-MMU-186797),1,+,5.69E-01,8.25E-01,1.22E+00,,,,,,,
NCAM1 interactions (R-MMU-419037),1,+,5.66E-01,8.20E-01,1.20E+00,,,,,,,
Metal ion SLC transporters (R-MMU-425410),1,-,5.82E-01,8.15E-01,1.19E+00,,,,,,,
"Transport of bile salts and organic acids, metal ions and amine compounds (R-MMU-425366)",1,-,5.79E-01,8.11E-01,1.18E+00,,,,,,,
Vitamin D (calciferol) metabolism (R-MMU-196791),1,+,5.84E-01,8.16E-01,1.17E+00,,,,,,,
Common Pathway of Fibrin Clot Formation (R-MMU-140875),1,+,5.90E-01,8.43E-01,1.16E+00,,,,,,,
Metabolism of steroid hormones (R-MMU-196071),1,-,5.91E-01,8.40E-01,1.15E+00,,,,,,,
Fructose biosynthesis (R-MMU-5652227),1,-,5.88E-01,8.35E-01,1.17E+00,,,,,,,
Fructose metabolism (R-MMU-5652084),1,-,5.86E-01,8.38E-01,9.70E-01,,,,,,,
Pregnenolone biosynthesis (R-MMU-196108),1,-,5.83E-01,8.34E-01,9.65E-01,,,,,,,
Basigin interactions (R-MMU-210991),1,-,6.15E-01,8.55E-01,9.60E-01,,,,,,,
Activation of Matrix Metalloproteinases (R-MMU-1592389),1,+,6.24E-01,8.50E-01,9.54E-01,,,,,,,
RUNX1 regulates transcription of genes involved in differentiation of keratinocytes (R-MMU-8939242),1,+,6.21E-01,8.46E-01,9.49E-01,,,,,,,
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers (R-MMU-983695),1,+,6.27E-01,8.42E-01,9.83E-01,,,,,,,
Mitochondrial protein import (R-MMU-1268020),1,-,6.25E-01,8.59E-01,9.78E-01,,,,,,,
CD22 mediated BCR regulation (R-MMU-5690714),1,+,6.22E-01,8.55E-01,9.72E-01,,,,,,,
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion (R-MMU-399955),1,+,6.28E-01,8.51E-01,9.67E-01,,,,,,,
Nephrin family interactions (R-MMU-373753),1,+,6.46E-01,8.47E-01,9.62E-01,,,,,,,
Intrinsic Pathway of Fibrin Clot Formation (R-MMU-140837),1,-,6.81E-01,8.43E-01,9.57E-01,,,,,,,
Signaling by ERBB4 (R-MMU-1236394),1,-,6.89E-01,8.60E-01,9.52E-01,,,,,,,
HDR through Homologous Recombination (HRR) (R-MMU-5685942),1,-,6.86E-01,8.56E-01,9.47E-01,,,,,,,
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation (R-MMU-975163),1,-,6.84E-01,8.52E-01,9.42E-01,,,,,,,
Downregulation of ERBB2:ERBB3 signaling (R-MMU-1358803),1,-,6.81E-01,8.48E-01,9.37E-01,,,,,,,
Regulation of signaling by CBL (R-MMU-912631),1,-,6.79E-01,8.47E-01,9.32E-01,,,,,,,
RIPK1-mediated regulated necrosis (R-MMU-5213460),1,-,6.76E-01,9.00E-01,9.27E-01,,,,,,,
Recognition of DNA damage by PCNA-containing replication complex (R-MMU-110314),1,-,6.74E-01,8.76E-01,9.23E-01,,,,,,,
Negative regulation of MET activity (R-MMU-6807004),1,-,6.71E-01,8.73E-01,9.18E-01,,,,,,,
Translesion synthesis by REV1 (R-MMU-110312),1,-,6.69E-01,8.80E-01,9.13E-01,,,,,,,
Regulation of PTEN localization (R-MMU-8948747),1,-,6.67E-01,8.94E-01,9.09E-01,,,,,,,
Dual Incision in GG-NER (R-MMU-5696400),1,-,6.64E-01,8.91E-01,9.04E-01,,,,,,,
E3 ubiquitin ligases ubiquitinate target proteins (R-MMU-8866654),1,-,6.62E-01,8.92E-01,9.00E-01,,,,,,,
Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon (R-MMU-936964),1,-,6.59E-01,8.88E-01,8.95E-01,,,,,,,
Dual incision in TC-NER (R-MMU-6782135),1,-,6.57E-01,8.89E-01,8.91E-01,,,,,,,
Transcription-Coupled Nucleotide Excision Repair (TC-NER) (R-MMU-6781827),1,-,6.55E-01,8.86E-01,8.87E-01,,,,,,,
Formation of TC-NER Pre-Incision Complex (R-MMU-6781823),1,-,6.52E-01,8.83E-01,8.82E-01,,,,,,,
Spry regulation of FGF signaling (R-MMU-1295596),1,-,6.50E-01,8.87E-01,8.78E-01,,,,,,,
Signaling by NOTCH1 (R-MMU-1980143),1,-,6.48E-01,8.84E-01,8.74E-01,,,,,,,
Negative regulators of DDX58/IFIH1 signaling (R-MMU-936440),1,-,6.45E-01,8.81E-01,8.69E-01,,,,,,,
Oncogene Induced Senescence (R-MMU-2559585),1,-,6.43E-01,8.91E-01,8.65E-01,,,,,,,
Activated NOTCH1 Transmits Signal to the Nucleus (R-MMU-2122948),1,-,6.41E-01,8.88E-01,8.61E-01,,,,,,,
Endosomal Sorting Complex Required For Transport (ESCRT) (R-MMU-917729),1,-,6.39E-01,8.95E-01,8.57E-01,,,,,,,
TRAF6-mediated induction of TAK1 complex within TLR4 complex (R-MMU-937072),1,-,6.37E-01,8.92E-01,8.53E-01,,,,,,,
Deactivation of the beta-catenin transactivating complex (R-MMU-3769402),1,-,6.34E-01,8.89E-01,8.49E-01,,,,,,,
APC/C:Cdc20 mediated degradation of Cyclin B (R-MMU-174048),1,-,6.32E-01,8.86E-01,8.45E-01,,,,,,,
IRAK2 mediated activation of TAK1 complex (R-MMU-937042),1,-,6.30E-01,8.83E-01,8.41E-01,,,,,,,
IKK complex recruitment mediated by RIP1 (R-MMU-937041),1,-,6.28E-01,8.81E-01,8.37E-01,,,,,,,
Metalloprotease DUBs (R-MMU-5689901),1,-,6.26E-01,8.91E-01,8.33E-01,,,,,,,
PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 (R-MMU-8849469),1,-,6.24E-01,8.89E-01,8.30E-01,,,,,,,
Regulation of TP53 Expression and Degradation (R-MMU-6806003),1,-,6.21E-01,9.00E-01,8.26E-01,,,,,,,
Termination of translesion DNA synthesis (R-MMU-5656169),1,-,6.19E-01,8.98E-01,8.22E-01,,,,,,,
Translesion synthesis by POLK (R-MMU-5655862),1,-,6.17E-01,8.95E-01,8.18E-01,,,,,,,
Regulated Necrosis (R-MMU-5218859),1,-,6.15E-01,8.92E-01,8.15E-01,,,,,,,
Regulation of innate immune responses to cytosolic DNA (R-MMU-3134975),1,-,6.13E-01,8.89E-01,8.11E-01,,,,,,,
Translesion synthesis by POLI (R-MMU-5656121),1,-,6.11E-01,8.88E-01,8.07E-01,,,,,,,
Downregulation of ERBB4 signaling (R-MMU-1253288),1,-,6.09E-01,8.86E-01,8.04E-01,,,,,,,
NRIF signals cell death from the nucleus (R-MMU-205043),1,-,6.07E-01,8.96E-01,8.00E-01,,,,,,,
Fanconi Anemia Pathway (R-MMU-6783310),1,-,6.05E-01,8.87E-01,7.97E-01,,,,,,,
Signaling by EGFR (R-MMU-177929),1,-,6.03E-01,8.85E-01,7.93E-01,,,,,,,
Signaling by FGFR4 (R-MMU-5654743),1,-,6.01E-01,8.82E-01,7.90E-01,,,,,,,
Signaling by FGFR3 (R-MMU-5654741),1,-,5.99E-01,8.80E-01,7.86E-01,,,,,,,
Gap-filling DNA repair synthesis and ligation in GG-NER (R-MMU-5696397),1,-,5.97E-01,8.77E-01,7.83E-01,,,,,,,
Signaling by FGFR1 (R-MMU-5654736),1,-,5.95E-01,8.82E-01,7.80E-01,,,,,,,
Negative regulation of FGFR4 signaling (R-MMU-5654733),1,-,5.93E-01,8.79E-01,7.76E-01,,,,,,,
Negative regulation of FGFR3 signaling (R-MMU-5654732),1,-,5.91E-01,9.04E-01,7.73E-01,,,,,,,
Gap-filling DNA repair synthesis and ligation in TC-NER (R-MMU-6782210),1,-,5.90E-01,9.11E-01,7.70E-01,,,,,,,
Regulation of expression of SLITs and ROBOs (R-MMU-9010553),1,-,5.88E-01,9.39E-01,7.66E-01,,,,,,,
Negative regulation of FGFR2 signaling (R-MMU-5654727),1,-,5.86E-01,9.36E-01,7.63E-01,,,,,,,
Negative regulation of FGFR1 signaling (R-MMU-5654726),1,-,5.84E-01,9.33E-01,7.60E-01,,,,,,,
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) (R-MMU-5693567),1,-,5.82E-01,9.31E-01,7.57E-01,,,,,,,
NOD1/2 Signaling Pathway (R-MMU-168638),1,-,5.80E-01,9.33E-01,7.54E-01,,,,,,,
Regulation of necroptotic cell death (R-MMU-5675482),1,-,5.78E-01,9.31E-01,7.50E-01,,,,,,,
Homology Directed Repair (R-MMU-5693538),1,-,5.77E-01,9.28E-01,7.47E-01,,,,,,,
"Interleukin-3, Interleukin-5 and GM-CSF signaling (R-MMU-512988)",1,-,5.75E-01,9.28E-01,7.44E-01,,,,,,,
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1 (R-MMU-450321),1,-,5.73E-01,9.26E-01,7.41E-01,,,,,,,
NF-kB is activated and signals survival (R-MMU-209560),1,-,5.71E-01,9.24E-01,7.38E-01,,,,,,,
activated TAK1 mediates p38 MAPK activation (R-MMU-450302),1,-,5.70E-01,9.21E-01,7.35E-01,,,,,,,
p75NTR signals via NF-kB (R-MMU-193639),1,-,5.68E-01,9.19E-01,7.32E-01,,,,,,,
Regulation of TP53 Activity through Methylation (R-MMU-6804760),1,-,5.66E-01,9.16E-01,7.29E-01,,,,,,,
Regulation of TP53 Degradation (R-MMU-6804757),1,-,5.64E-01,9.14E-01,7.26E-01,,,,,,,
Regulation of TP53 Activity through Phosphorylation (R-MMU-6804756),1,-,5.63E-01,9.12E-01,7.23E-01,,,,,,,
p75NTR recruits signalling complexes (R-MMU-209543),1,-,5.61E-01,9.09E-01,7.21E-01,,,,,,,
Regulation of FZD by ubiquitination (R-MMU-4641263),1,-,5.59E-01,9.07E-01,7.18E-01,,,,,,,
ER Quality Control Compartment (ERQC) (R-MMU-901032),1,-,5.57E-01,9.05E-01,7.15E-01,,,,,,,
EGFR downregulation (R-MMU-182971),1,-,5.56E-01,9.02E-01,7.12E-01,,,,,,,
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription (R-MMU-2173796),1,-,5.54E-01,9.00E-01,7.09E-01,,,,,,,
Downregulation of SMAD2/3:SMAD4 transcriptional activity (R-MMU-2173795),1,-,5.52E-01,8.98E-01,7.35E-01,,,,,,,
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer (R-MMU-2173793),1,-,5.51E-01,8.96E-01,7.57E-01,,,,,,,
TGF-beta receptor signaling activates SMADs (R-MMU-2173789),1,-,5.49E-01,8.93E-01,7.81E-01,,,,,,,
Downregulation of TGF-beta receptor signaling (R-MMU-2173788),1,-,5.47E-01,8.91E-01,7.78E-01,,,,,,,
Josephin domain DUBs (R-MMU-5689877),1,-,5.46E-01,8.89E-01,7.85E-01,,,,,,,
APC-Cdc20 mediated degradation of Nek2A (R-MMU-179409),1,-,5.44E-01,8.87E-01,7.82E-01,,,,,,,
Insulin effects increased synthesis of Xylulose-5-Phosphate (R-MMU-163754),1,-,5.52E-01,8.85E-01,7.79E-01,,,,,,,
Pentose phosphate pathway (R-MMU-71336),1,-,5.50E-01,8.82E-01,7.76E-01,,,,,,,
PTK6 Regulates Proteins Involved in RNA Processing (R-MMU-8849468),1,+,5.49E-01,8.80E-01,7.74E-01,,,,,,,
Integration of energy metabolism (R-MMU-163685),1,-,5.47E-01,8.78E-01,7.71E-01,,,,,,,
CLEC7A/inflammasome pathway (R-MMU-5660668),1,+,5.50E-01,8.76E-01,7.68E-01,,,,,,,
Netrin-1 signaling (R-MMU-373752),1,+,5.60E-01,8.74E-01,7.65E-01,,,,,,,
Reversible hydration of carbon dioxide (R-MMU-1475029),1,-,5.68E-01,8.72E-01,7.63E-01,,,,,,,
Respiratory electron transport (R-MMU-611105),1,+,5.66E-01,8.69E-01,7.72E-01,,,,,,,
Metabolism of Angiotensinogen to Angiotensins (R-MMU-2022377),1,+,5.69E-01,8.67E-01,8.02E-01,,,,,,,
Noncanonical activation of NOTCH3 (R-MMU-9017802),1,-,5.68E-01,8.65E-01,7.99E-01,,,,,,,
Peptide hormone metabolism (R-MMU-2980736),1,+,5.66E-01,8.63E-01,8.02E-01,,,,,,,
WNT ligand biogenesis and trafficking (R-MMU-3238698),1,+,5.82E-01,8.61E-01,8.09E-01,,,,,,,
VEGFR2 mediated vascular permeability (R-MMU-5218920),1,-,6.03E-01,8.59E-01,8.27E-01,,,,,,,
eNOS activation and regulation (R-MMU-203765),1,-,6.01E-01,8.57E-01,8.34E-01,,,,,,,
Metabolism of cofactors (R-MMU-8978934),1,-,6.00E-01,8.55E-01,8.38E-01,,,,,,,
Metabolism of nitric oxide (R-MMU-202131),1,-,5.98E-01,8.53E-01,8.36E-01,,,,,,,
eNOS activation (R-MMU-203615),1,-,5.97E-01,8.51E-01,8.33E-01,,,,,,,
"Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation (R-MMU-1474151)",1,-,5.95E-01,8.49E-01,8.31E-01,,,,,,,
Vasopressin regulates renal water homeostasis via Aquaporins (R-MMU-432040),1,+,5.99E-01,8.47E-01,8.28E-01,,,,,,,
Aquaporin-mediated transport (R-MMU-445717),1,+,5.98E-01,8.45E-01,8.26E-01,,,,,,,
Prolactin receptor signaling (R-MMU-1170546),1,-,6.15E-01,8.43E-01,8.23E-01,,,,,,,
Bile acid and bile salt metabolism (R-MMU-194068),1,-,6.45E-01,8.41E-01,8.21E-01,,,,,,,
Recycling of bile acids and salts (R-MMU-159418),1,-,6.43E-01,8.39E-01,8.26E-01,,,,,,,
"Transport of vitamins, nucleosides, and related molecules (R-MMU-425397)",1,-,6.42E-01,8.37E-01,8.23E-01,,,,,,,
Transport of organic anions (R-MMU-879518),1,-,6.40E-01,8.35E-01,8.57E-01,,,,,,,
Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) (R-MMU-400206),1,+,6.56E-01,8.33E-01,8.55E-01,,,,,,,
KSRP (KHSRP) binds and destabilizes mRNA (R-MMU-450604),1,-,6.82E-01,8.31E-01,8.01E-01,,,,,,,
Interleukin-4 and Interleukin-13 signaling (R-MMU-6785807),1,-,6.91E-01,8.29E-01,7.99E-01,,,,,,,
Apoptosis induced DNA fragmentation (R-MMU-140342),1,-,6.87E-01,8.27E-01,7.97E-01,,,,,,,
Activation of DNA fragmentation factor (R-MMU-211227),1,-,6.86E-01,8.25E-01,7.95E-01,,,,,,,
ZBP1(DAI) mediated induction of type I IFNs (R-MMU-1606322),1,-,6.84E-01,8.23E-01,8.00E-01,,,,,,,
Advanced glycosylation endproduct receptor signaling (R-MMU-879415),1,-,6.83E-01,8.21E-01,7.98E-01,,,,,,,
DEx/H-box helicases activate type I IFN and inflammatory cytokines production  (R-MMU-3134963),1,-,6.81E-01,8.20E-01,7.91E-01,,,,,,,
RIP-mediated NFkB activation via ZBP1 (R-MMU-1810476),1,-,6.80E-01,8.18E-01,8.00E-01,,,,,,,
TRAF6 mediated NF-kB activation (R-MMU-933542),1,-,6.78E-01,8.16E-01,7.98E-01,,,,,,,
VLDL assembly (R-MMU-8866423),1,+,6.96E-01,8.14E-01,7.96E-01,,,,,,,
Interleukin-23 signaling (R-MMU-9020933),1,+,6.95E-01,8.12E-01,7.95E-01,,,,,,,
Interleukin-12 family signaling (R-MMU-447115),1,+,6.93E-01,8.10E-01,7.93E-01,,,,,,,
Interleukin-12 signaling (R-MMU-9020591),1,+,6.92E-01,8.08E-01,7.91E-01,,,,,,,
SUMOylation of RNA binding proteins (R-MMU-4570464),1,-,7.12E-01,8.07E-01,7.89E-01,,,,,,,
Regulation of Glucokinase by Glucokinase Regulatory Protein (R-MMU-170822),1,-,7.10E-01,8.05E-01,8.11E-01,,,,,,,
snRNP Assembly (R-MMU-191859),1,-,7.09E-01,8.03E-01,8.33E-01,,,,,,,
SUMOylation of DNA replication proteins (R-MMU-4615885),1,-,7.07E-01,8.01E-01,8.47E-01,,,,,,,
SUMOylation of DNA damage response and repair proteins (R-MMU-3108214),1,-,7.06E-01,7.99E-01,8.45E-01,,,,,,,
SUMOylation of SUMOylation proteins (R-MMU-4085377),1,-,7.04E-01,7.98E-01,8.43E-01,,,,,,,
SUMOylation of ubiquitinylation proteins (R-MMU-3232142),1,-,7.03E-01,7.96E-01,8.80E-01,,,,,,,
Nuclear Pore Complex (NPC) Disassembly (R-MMU-3301854),1,-,7.01E-01,7.94E-01,8.85E-01,,,,,,,
Metabolism of non-coding RNA (R-MMU-194441),1,-,7.00E-01,7.92E-01,8.83E-01,,,,,,,
Butyrophilin (BTN) family interactions (R-MMU-8851680),1,+,7.08E-01,7.90E-01,8.82E-01,,,,,,,
Synthesis of Prostaglandins (PG) and Thromboxanes (TX) (R-MMU-2162123),1,+,7.19E-01,7.89E-01,8.80E-01,,,,,,,
RNA Polymerase I Transcription Termination (R-MMU-73863),1,-,7.34E-01,7.87E-01,9.18E-01,,,,,,,
Transferrin endocytosis and recycling (R-MMU-917977),1,-,7.42E-01,7.85E-01,9.16E-01,,,,,,,
HDL assembly (R-MMU-8963896),1,-,7.51E-01,7.83E-01,9.14E-01,,,,,,,
Scavenging by Class B Receptors (R-MMU-3000471),1,-,7.49E-01,8.06E-01,9.12E-01,,,,,,,
ABC transporters in lipid homeostasis (R-MMU-1369062),1,-,7.48E-01,8.04E-01,9.30E-01,,,,,,,
Formyl peptide receptors bind formyl peptides and many other ligands (R-MMU-444473),1,+,7.56E-01,8.02E-01,9.31E-01,,,,,,,
Carboxyterminal post-translational modifications of tubulin (R-MMU-8955332),1,-,7.66E-01,8.01E-01,9.29E-01,,,,,,,
Transport of connexons to the plasma membrane (R-MMU-190872),1,-,7.65E-01,7.99E-01,9.36E-01,,,,,,,
Gap junction assembly (R-MMU-190861),1,-,7.63E-01,7.97E-01,9.34E-01,,,,,,,
Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane (R-MMU-190840),1,-,7.62E-01,7.96E-01,9.32E-01,,,,,,,
Intraflagellar transport (R-MMU-5620924),1,-,7.60E-01,8.13E-01,9.30E-01,,,,,,,
Activation of C3 and C5 (R-MMU-174577),1,+,7.90E-01,8.18E-01,9.29E-01,,,,,,,
Alternative complement activation (R-MMU-173736),1,+,7.88E-01,8.27E-01,9.42E-01,,,,,,,
TNFR1-mediated ceramide production (R-MMU-5626978),1,-,7.96E-01,8.25E-01,9.40E-01,,,,,,,
Regulation of cytoskeletal remodeling and cell spreading by IPP complex components (R-MMU-446388),1,+,8.35E-01,8.50E-01,9.39E-01,,,,,,,
Interferon Signaling (R-MMU-913531),1,+,8.55E-01,8.69E-01,9.37E-01,,,,,,,
Antiviral mechanism by IFN-stimulated genes (R-MMU-1169410),1,+,8.53E-01,8.64E-01,9.35E-01,,,,,,,
ISG15 antiviral mechanism (R-MMU-1169408),1,+,8.51E-01,8.67E-01,9.33E-01,,,,,,,
Formation of Senescence-Associated Heterochromatin Foci (SAHF) (R-MMU-2559584),1,+,8.65E-01,8.66E-01,9.31E-01,,,,,,,
Breakdown of the nuclear lamina (R-MMU-352238),1,+,8.63E-01,8.64E-01,9.42E-01,,,,,,,
Depolymerisation of the Nuclear Lamina (R-MMU-4419969),1,+,8.62E-01,8.62E-01,9.44E-01,,,,,,,
Cleavage of Growing Transcript in the Termination Region  (R-MMU-109688),1,-,8.76E-01,8.61E-01,9.42E-01,,,,,,,
mRNA 3'-end processing (R-MMU-72187),1,-,8.75E-01,8.59E-01,9.41E-01,,,,,,,
RNA Polymerase II Transcription Termination (R-MMU-73856),1,-,8.73E-01,8.58E-01,9.58E-01,,,,,,,
Dissolution of Fibrin Clot (R-MMU-75205),1,+,8.78E-01,8.79E-01,9.56E-01,,,,,,,
Intracellular oxygen transport (R-MMU-8981607),1,-,9.22E-01,8.78E-01,9.55E-01,,,,,,,
Platelet calcium homeostasis (R-MMU-418360),1,-,9.27E-01,8.76E-01,9.53E-01,,,,,,,
Reduction of cytosolic Ca++ levels (R-MMU-418359),1,-,9.25E-01,8.84E-01,9.62E-01,,,,,,,
Platelet homeostasis (R-MMU-418346),1,-,9.24E-01,8.83E-01,9.61E-01,,,,,,,
Ion transport by P-type ATPases (R-MMU-936837),1,-,9.22E-01,8.81E-01,9.59E-01,,,,,,,
Neurotransmitter clearance (R-MMU-112311),1,-,9.27E-01,8.79E-01,9.57E-01,,,,,,,
Ethanol oxidation (R-MMU-71384),1,-,9.25E-01,8.91E-01,9.59E-01,,,,,,,
Serotonin clearance from the synaptic cleft (R-MMU-380615),1,-,9.24E-01,8.90E-01,9.57E-01,,,,,,,
Metabolism of serotonin (R-MMU-380612),1,-,9.22E-01,8.88E-01,9.55E-01,,,,,,,
Rho GTPase cycle (R-MMU-194840),1,-,9.27E-01,8.86E-01,9.54E-01,,,,,,,
RNA Polymerase I Transcription Initiation (R-MMU-73762),1,+,9.21E-01,9.08E-01,9.52E-01,,,,,,,
Regulation of PTEN gene transcription (R-MMU-8943724),1,+,9.19E-01,9.06E-01,9.51E-01,,,,,,,
Transcriptional Regulation by E2F6 (R-MMU-8953750),1,+,9.18E-01,9.04E-01,9.49E-01,,,,,,,
Regulation of TP53 Activity through Acetylation (R-MMU-6804758),1,+,9.16E-01,9.03E-01,9.58E-01,,,,,,,
G0 and Early G1 (R-MMU-1538133),1,+,9.15E-01,9.01E-01,9.57E-01,,,,,,,
Activation of NMDA receptor and postsynaptic events (R-MMU-442755),1,-,9.43E-01,9.00E-01,9.63E-01,,,,,,,
CREB phosphorylation through the activation of Ras (R-MMU-442742),1,-,9.41E-01,8.98E-01,9.61E-01,,,,,,,
CREB phosphorylation through the activation of CaMKII (R-MMU-442729),1,-,9.40E-01,9.17E-01,9.60E-01,,,,,,,
Neurotransmitter receptors and postsynaptic signal transmission (R-MMU-112314),1,-,9.38E-01,9.19E-01,9.81E-01,,,,,,,
Synthesis of 15-eicosatetraenoic acid derivatives (R-MMU-2142770),1,+,9.37E-01,9.17E-01,9.79E-01,,,,,,,
Synthesis of 12-eicosatetraenoic acid derivatives (R-MMU-2142712),1,+,9.35E-01,9.41E-01,9.78E-01,,,,,,,
"Unblocking of NMDA receptor, glutamate binding and activation (R-MMU-438066)",1,-,9.34E-01,9.75E-01,9.76E-01,,,,,,,
Post NMDA receptor activation events (R-MMU-438064),1,-,9.32E-01,9.77E-01,9.75E-01,,,,,,,
Ras activation upon Ca2+ influx through NMDA receptor (R-MMU-442982),1,-,9.31E-01,9.83E-01,9.73E-01,,,,,,,
Purine catabolism (R-MMU-74259),1,+,9.29E-01,9.81E-01,9.83E-01,,,,,,,
Nucleobase catabolism (R-MMU-8956319),1,+,9.28E-01,9.84E-01,9.85E-01,,,,,,,
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding (R-MMU-6814122),1,-,9.52E-01,9.83E-01,9.83E-01,,,,,,,
Adherens junctions interactions (R-MMU-418990),1,+,9.50E-01,9.81E-01,9.82E-01,,,,,,,
Protein folding (R-MMU-391251),1,-,9.49E-01,9.79E-01,9.80E-01,,,,,,,
Association of TriC/CCT with target proteins during biosynthesis (R-MMU-390471),1,-,9.47E-01,9.78E-01,9.79E-01,,,,,,,
Chaperonin-mediated protein folding (R-MMU-390466),1,-,9.46E-01,9.76E-01,9.77E-01,,,,,,,
RHO GTPases Activate WASPs and WAVEs (R-MMU-5663213),1,+,9.44E-01,9.75E-01,9.76E-01,,,,,,,
Cell-cell junction organization (R-MMU-421270),1,+,9.43E-01,9.73E-01,9.96E-01,,,,,,,
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest (R-MMU-6804114),1,+,9.50E-01,9.72E-01,9.94E-01,,,,,,,
TP53 Regulates Transcription of Cell Cycle Genes (R-MMU-6791312),1,+,9.49E-01,9.86E-01,9.96E-01,,,,,,,
Lysine catabolism (R-MMU-71064),1,+,9.51E-01,9.85E-01,9.99E-01,,,,,,,
"Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism (R-MMU-6788656)",1,+,9.49E-01,9.83E-01,9.98E-01,,,,,,,
Neurotransmitter release cycle (R-MMU-112310),1,+,9.77E-01,9.93E-01,9.92E-01,,,,,,,
"GABA synthesis, release, reuptake and degradation (R-MMU-888590)",1,+,9.75E-01,9.75E-01,9.90E-01,,,,,,,
